Evaluate the Safety of Linaclotide in IBS-C Patients in China

Clinical trial NCT04462900 · COMPLETED

Trial details

NCT number: NCT04462900
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Irritable Bowel Syndrome-IBS

Start date: 2020-09-18
Primary completion: 2023-02-03
Enrollment: 3028

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.